 |
0 Diseases |  |
0 Trials |
|
0 Trials |  |
9 News |  |
- ||| AC-083 / J&J
Trial completion: First-in-man Study of Single Ascending Dose of a New Drug for Neurological Disorders (clinicaltrials.gov) - Jan 17, 2017
P1, N=72, Completed, Sponsor: Actelion
Recruiting --> Completed
- ||| AC-083 / J&J
Enrollment open, Enrollment change: First-in-man Study of Single Ascending Dose of a New Drug for Neurological Disorders (clinicaltrials.gov) - Nov 2, 2016
P1, N=72, Recruiting, Sponsor: Actelion
Recruiting --> Completed Active, not recruiting --> Recruiting | N=48 --> 72
- AC-083 / J&J
Trial primary completion date: First-in-man Study of Single Ascending Dose of a New Drug for Neurological Disorders (clinicaltrials.gov) - Aug 24, 2016
P1, N=48, Active, not recruiting, Sponsor: Actelion
Active, not recruiting --> Recruiting | N=48 --> 72 Trial primary completion date: Jul 2016 --> Feb 2017
- AC-083 / J&J
Enrollment closed: First-in-man Study of Single Ascending Dose of a New Drug for Neurological Disorders (clinicaltrials.gov) - Jul 5, 2016
P1, N=48, Active, not recruiting, Sponsor: Actelion
Trial primary completion date: Jul 2016 --> Feb 2017 Recruiting --> Active, not recruiting
- | AC-083 / J&J
New P1 trial: First-in-man Study of Single Ascending Dose of a New Drug for Neurological Disorders (clinicaltrials.gov) - Mar 25, 2016
P1, N=48, Recruiting, Sponsor: Actelion